Concepedia

Author

Amarnath Natarajan

University of Nebraska Medical CenterORCID

Also Known As

A NATARAJAN, A Natarajan, A. Natarajan, Amarnath Natarajan, Jayapal Reddy Mallareddy, Natarajan, Amarnath

213

Publications

3.5K

Citations

32

H-Index

97

Concepts

All Affiliations

University of Nebraska Medical CenterThe University of Texas Medical Branch at GalvestonNebraska Medical CenterHarvard UniversityBrigham and Women's Hospital
AN

About

Amarnath Natarajan is an author at University of Nebraska Medical Center specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

34

1.2K

2

Natural Sciences

16

24

811

3

Biochemistry

16

24

804

4

Engineering

6

6

197

5

Health Sciences

2

2

78

Amarnath Natarajan

×

75

Publications

3K

Citations

31

H-Index

YearCitations

Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Caroline M. Robb, Jacob I. Contreras, Smit Kour,

Chemical Communications

2017

206

Impact of structurally modifying hyaluronic acid on CD44 interaction

Deep Bhattacharya, Denis Svechkarev, Joshua J. Souchek,

Journal of Materials Chemistry B

2017

194

Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation

Amarnath Natarajan, Yuhong Guo, Frederick Harbinski,

Journal of Medicinal Chemistry

2004

185

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy

Yogesh A. Sonawane, Margaret Taylor, John V. Napoleon,

Journal of Medicinal Chemistry

2016

149

Selective degradation of CDK6 by a palbociclib based PROTAC

Sandeep Rana, Mourad Bendjennat, Smit Kour,

Bioorganic & Medicinal Chemistry Letters

2019

128

Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure–Activity Relationship Study

Sandeep Rana, Elizabeth C. Blowers, Calvin Tebbe,

Journal of Medicinal Chemistry

2016

111

3,3-Diaryl-1,3-dihydroindol-2-ones as Antiproliferatives Mediated by Translation Initiation Inhibition

Amarnath Natarajan, Yun-Hua Fan, Han Chen,

Journal of Medicinal Chemistry

2004

97

Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers

Srikumar M. Raja, Robert J. Clubb, Cesar F. Ortega-Cava,

Cancer Biology & Therapy

2011

78

RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment

Ashley L. Hein, Carl M. Post, Yuri Sheinin,

Oncogene

2016

65

Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis

Divya Murthy, Kuldeep S. Attri, Surendra K. Shukla,

Nature Cell Biology

2024

65

Page 1